A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib Protocolnummer: DCC-2618-03-002 EudraCT nummer: 2018-001803-35…
Validation of mutation analysis in circulating tumour DNA with a ddPCR assay as diagnostic and follow-up tool for patients with a KIT exon 11 mutated GIST: GALLOP-11. Protocolnummer:…
Samenvatting In het AVL is de TCR studie voor NY ESO pos synoviosarcoom patiënten open. Gemetastaseerde synoviosarcoom patiënten voor eerste lijns/tweedelijns behandeling kunnen geïncludeerd worden. Er is in…
International randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma Eudractnummer: 2014-000259-99 Dit is een prospectief, multicenter, gerandomiseerd en open-label fase II/fase…
A Phase 2, Randomized, Open-Label Study of Nivolumab Combined with Ipilimumab Versus Standard of Care in Subjects with Previously Untreated and Advanced (unresectable or metastatic) non-clear Cell Renal…
Watchful waiting in patients with good and intermediate risk metastatic renal cell carcinoma; an imaging guided observational approach. METcnummer: 2014.176 Onderzoekscode: O126 Samenvatting In een deel van de…
A Phase 3, Open-label, Randomized Study of Nivolumab Combined with Ipilimumab versus Standard of Care Chemotherapy in Participants with Previously Untreated Unresectable or Metastatic Urothelial Cancer (CheckMate 901:…
ICRA (Improve Checkpoint-blockade Response in Advanced urothelial cancer), an adaptive clinical study to determine efficacy of combining weekly paclitaxel with tremelimumab +/- durvalumab (MEDI4736) Protocolnummer: ESR-18-13667 EudraCT nummer:…
A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post- Surgery Therapy with Nivolumab or Nivolumab…
Short-term Testosterone replacement in testicular cancer survivors to treat overweight and improve cardiometabolic risk; a pilot study. METc nummer: 2017/436 Onderzoekscode: Samenvatting Het vaststellen van de effecten van…
Senescence and the early ageing phenotype after chemotherapy for testicular cancer. The SEA-CAT study Protocolnummer: 201700615 Eudractnummer: METc nummer: 2017/483 Onderzoekscode: Samenvatting Het doel van dit project is…
Vascular fingerprint to identify patients at risk for arterial cardiovascular events within the first year after start of cisplatin-based chemotherapy for testicular cancer: a validation study. METc nummer:…